Abstract Background White matter hyperintensity topography, particularly posterior confluent and subcortical multispot (WMH‐MS), has been implicated as surrogate imaging biomarker of cerebral amyloid angiopathy (CAA). Usefulness of WMH‐MS for prediction of future cerebral microbleeds (CMB's) has significant clinical implications for anti‐amyloid therapy risk assessment. Our primary goal was to identify the prevalence of positive WMH‐MS status and their utility for predicting the incident CMBs in a population‐based sample. Our secondary goal was to evaluate its usefulness after accounting for amyloid (surrogate for CAA) and WMH burden (surrogate of small vessel disease) which are both risk factors for CMBs. Method We identified 651 participants (mean age (SD) 69.8 (10.0) years, 55% male) from the Mayo Clinic Study of Aging, who had 3T baseline whole brain fluid‐attenuated inversion recovery (FLAIR) MRI and at least two T2*‐weighted gradient recalled echo (GRE) sequences (concomitant with or after FLAIR) which were used to ascertain CMBs. Amyloid positron emission tomography (PiB‐PET) scans were available in 87% of the sample. Visual reads on FLAIR scans were performed using a 4‐point Fazekas rating scale of periventricular and deep WMH (positivity: Fazekas ≥ 2) and a 3‐point MS severity visual scale (positivity: nWMH‐MS > 10 circular or ovoid WMH spots, Figure 1) according to established criteria. Using univariate and multivariable logistic regression, we assessed the independent association of WMH‐MS > 10 and Fazekas ≥ 2 for prediction of incident CMB's. Result The frequency of WMH‐MS pattern was greater in those who developed an incident CMB compared to those who did not develop a CMB (20.8% vs. 2.8%, p < 0.001). Older age and male sex were predictive of incident CMBs (Figure 2A). In univariate models, presence of WMH‐MS pattern but not Fazekas was associated with incident CMBs after adjusting for age and sex. The associations remained significant after additional adjustment for APOE4 , hypertension, number of baseline CMBs (Prior CMB), and amyloid effects (Figure 2B). Conclusion Visually identified WMH‐MS patterns on FLAIR‐MRI were predictive of incident CMBs in this population and may be useful markers of CAA. Future studies evaluating its utility as an additional biomarker of amyloid related imaging abnormalities in clinical trials are necessary.
Precise Estimation Of Heterogenous Global Tau Burden In The Brain Sheds Light On Cognitive Resilience Mechanisms
Abstract Background Cognitive resilience to Alzheimer's disease (AD) pathology has been widely studied, but distinguishing resilient individuals from those with typical tau pathologies remains challenging due to the overlap in imaging and plasma biomarker profiles. We hypothesize that our machine learning‐based (ML) tau heterogeneity score, THETA (JNUMED, July 2024), could serve as an effective marker of resilience and provide a better estimation of tau's temporal progression. Method Longitudinal imaging data from the Mayo Clinic Study of Aging (MCSA, n = 1834) and ADRC ( n = 246) were analyzed. Participants were categorized into typical AD and resilient groups using amyloid PiB‐PET (abnormal PiB‐PET≥25 Centiloid units), Flortaucipir (FTP‐PET) (meta‐ROI≥1.29 SUVr, ERC≥1.27 SUVr) and Mini‐Mental State Examination (MMSE). Typical AD was defined as abnormal PiB‐PET and abnormal FTP‐PET for both biomarkers (Figure 1). Resilience to AD pathology was determined by predicted values of MMSE >28 from a linear mixed effects model for cognitively unimpaired participants. In addition, a resistant group was broadly defined as having normal PiB‐PET. To capture the spatial heterogeneity of tau distribution in the brain, regional THETA scores were generated using ML model and visual ratings. Additionally, a progression model, Sampled Iterative Local Approximation (SILA), was fitted using AD and plasma biomarkers ( p ‐tau181 and GFAP) for validation. Result THETA identified regions of reduced tau uptake in the frontal, parietal, temporal, occipital, and limbic regions when compared to the typical AD group (Figure 2A). This was confirmed by the preserved cortical thickness in these same regions (Figure 2D). In addition, SILA showed THETA can distinguish global tau temporal progressions of typical AD, resilient, and resistant groups compared to the other biomarkers (Figure 3). Interestingly, the onset age for GFAP was younger for resilient and typical AD, indicating earlier onset of inflammation in the presence of pathology. Conclusion The significant regions identified by THETA, showing reduced tau and preserved cortical thickness, combined with the clear offset in progression models between resilient and typical AD, suggest that THETA may help uncover pathological tau mechanisms that differentiate these groups. These findings highlight the potential of THETA to provide valuable insights into resilience mechanisms and enhance our understanding of AD.
White Matter and Tau Pathology: Evidence for Propagation and Deterioration
Abstract Background White matter (WM) plays a dual role in interacting with tau pathology. There is an intricate dynamic relationship with WM acting as highways for tau spreading, while the increasing tau burden ultimately compromises WM health. We aimed at studying the associations between tau accumulation and WM integrity using longitudinal data with focus on sex differences. Method We included 374 participants who had longitudinal multishell diffusion MRI and flortaucipir PET (baseline mean age = 70.9 years, 52% male, 17% MCI/AD dementia) scans from the Mayo ADRC and Mayo Clinic Study of Aging. Rate of tau accumulation was calculated from the entorhinal cortex (ERC) and inferior temporal cortex (IT) SUVRs, with IT‐WM serving as the WM highway between the two regions. IT‐WM was defined by JHU “Eve” WM atlas, and its integrity was assessed using neurite density index (NDI), which reflects the packing density of neurites. Structural equation modeling (SEM) evaluated relationships between tau and WM metrics. Result At baseline, males and females showed no significant differences in tau SUVR or IT‐WM NDI ( p >0.05), though males had higher vascular risk and averaged two years older than females (Table 1). Figure 1a showed that baseline ERC‐tau influenced baseline IT‐tau, as well as both rate of ERC‐tau and baseline IT‐tau influenced rate of IT‐tau. After incorporating IT‐WM NDI as a mediator (Figure 1b), we discovered 1) baseline ERC‐tau influencing rate of IT‐tau accumulation through baseline IT‐WM NDI, suggesting the role of WM health in the rate of tau accumulation; 2) Rate of IT‐tau accumulation negatively affected follow‐up IT‐WM NDI suggesting the deterioration of WM health as tau accumulation progresses. These relationships were stronger in males compared to females. We also observed greater impact of vascular risk on WM health in males and greater rates of IT‐tau accumulation in females. Conclusion Our work sheds light on the mechanistic role of intact WM in tau accumulation (through dense microtubules and synaptic connections) and the deterioration of WM that is associated with higher rates of tau accumulation. We found interesting sex differences that warrant further investigation.